Expanding the life-changing benefits of cell therapies
Orca Bio is redefining the traditional transplant process by developing next-generation cell therapies with the goal of providing significantly better survival rates with dramatically fewer risks.
With our purified, high-precision investigational cell therapies we hope to not only replace patients' blood and immune systems with healthy ones, but also restore their lives.
We believe we can push past the field's current boundaries and redefine its future.
Orca Bio began operations in 2016 based on research conducted by our founders in the laboratory of stem cell pioneer Dr. Irv Weissman at Stanford University. Our founders were inspired by the advancements made in the cell therapy field but believed the risks and limitations that have plagued this area for decades were unacceptable.
Today we are focused on bringing this innovative research approach to patients. By combining proven scientific insights with a cell-sorting platform capable of single-cell accuracy, we are delivering purified, high-precision investigational cell therapies for patients.
Patients shouldn't have to settle for anything less
At Orca Bio, we are continuously working to ensure they won't have to.
The leadership team at Orca Bio includes our company founders and industry veterans who are focused on building on past advancements to redefine what the future could mean for patients.
Cofounder and Team Lead Operations
“The hope is that blood cancer becomes a disease that we can eradicate. I am honored to support this mission.”
Read Jeroen’s bio
Team Lead People
“To me, Orca Bio means giving people, who may not otherwise have any options, the hope for a longer and better quality of life.”
Read Giselle’s bio
Cofounder and Chief Executive Officer
“The idea that we can safely and effectively replace a patient’s blood and immune system is tremendously exciting because it can be used across many medical challenges for which we have no solutions today.”
Read Ivan’s bio
Cofounder and Team Lead Science
“Our technology forms the foundation for incredible potential impact by providing the basis for a cure for blood diseases and severe autoimmune disease.”
Read Nate’s bio
Team Lead Engineering
“It is exciting to be part of the team that developed the technology to enable T-cell manufacturing to finally scale for mass production. Patients are our motivation.”
Read Colm’s bio
Team Lead Commercial
“I'm excited to be at Orca Bio. Together we are working to change the outcomes of treatment for patients, with the goal of ultimately saving and enhancing lives.”
Read Dan's bio
Team Lead Clinical Development
“Working at Orca Bio has given me the opportunity to try to change the treatment landscape for patients, and I feel very fortunate to have been given this opportunity.”
Read Scott's bio
Team Lead Finance & Strategy
“I'm motivated by working with teammates from a wide array of backgrounds coming together with a singular purpose: to deliver hope to patients.”
Read Josh's bio
Since our founding, the leadership team continues to deliver on its mission
Orca Bio is swiftly advancing our investigational therapies from their foundational science into the clinic.
Scientific advisors and directors
The leadership team at Orca Bio is supported by a senior team of advisors, comprised of industry pioneers committed to revolutionizing the field, so we can fulfill the promise of our vision to deliver a cure without compromise.